BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Passani A, Posarelli C, Sframeli AT, Perciballi L, Pellegrini M, Guidi G, Figus M. Cannabinoids in Glaucoma Patients: The Never-Ending Story. J Clin Med 2020;9:E3978. [PMID: 33302608 DOI: 10.3390/jcm9123978] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Vallée A, Lecarpentier Y, Vallée JN. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma. Int J Mol Sci 2021;22:3798. [PMID: 33917605 DOI: 10.3390/ijms22073798] [Reference Citation Analysis]
2 Bouskila J, Bleau M, Micaelo-Fernandes C, Bouchard JF, Ptito M. The Vertical and Horizontal Pathways in the Monkey Retina Are Modulated by Typical and Atypical Cannabinoid Receptors. Cells 2021;10:3160. [PMID: 34831383 DOI: 10.3390/cells10113160] [Reference Citation Analysis]
3 Jordan E, Nguyen GN, Piechot A, Kayser O. Cannabinoids as New Drug Candidates for the Treatment of Glaucoma. Planta Med 2022. [PMID: 35299275 DOI: 10.1055/a-1665-3100] [Reference Citation Analysis]
4 Fahmideh F, Marchesi N, Barbieri A, Govoni S, Pascale A. Non-drug interventions in glaucoma: Putative roles for lifestyle, diet and nutritional supplements. Surv Ophthalmol 2021:S0039-6257(21)00185-5. [PMID: 34563531 DOI: 10.1016/j.survophthal.2021.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mohan N, Chakrabarti A, Nazm N, Mehta R, Edward DP. Newer advances in medical management of glaucoma. Indian J Ophthalmol 2022;70:1920-30. [PMID: 35647957 DOI: 10.4103/ijo.IJO_2239_21] [Reference Citation Analysis]
6 Abyadeh M, Gupta V, Paulo JA, Gupta V, Chitranshi N, Godinez A, Saks D, Hasan M, Amirkhani A, McKay M, Salekdeh GH, Haynes PA, Graham SL, Mirzaei M. A Proteomic View of Cellular and Molecular Effects of Cannabis. Biomolecules 2021;11:1411. [PMID: 34680044 DOI: 10.3390/biom11101411] [Reference Citation Analysis]